Radnet Inc Revenue per Employee (RDNT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Radnet Inc   (NASDAQ: RDNT)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Radnet Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 24.99% in the second quarter 2026, year on year to cumulative value of $2,269 million, Radnet Inc 's revenue per employee grew on a trailing twelve months basis to $ 288,228, this marks a new company high.
Within the Healthcare sector Employees of 334 other companies have achieved higher revenue per employee. While Radnet Inc 's total ranking has deteriorated compared to the previous quarter from 2019 to 2618. Radnet Inc has 7,872 employees.


What is Sales per Employee Ratio?







RDNT Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 24.99 % 22.11 % 14.8 % 13.39 % 8.38 %
Sales per Employee (TTM) $ 288,228 272,414 259,173 250,203 242,362
RDNT's Total Ranking # 2618 # 2019 # 1740 # 2448 # 1984
Seq. Revenue Change 8.18 % 5.1 % 4.75 % 4.95 % 5.69 %


Revenue per Employee Company Ranking
Within: No.
Medical Laboratories Industry # 18
Healthcare Sector # 335
Overall Market # 2618

Revenue per Employee Statistics
High Average Low
$ 288,228 $ 151,063 $ 20,846
(Jun 30 2026)   (Sep 30 2013)



Financial Statements
Radnet Inc 's Revenue MRQ $ 623 Millions Visit RDNT's Income Statement
Radnet Inc 's Revenues TTM $ 2,269 Millions Visit RDNT's aggregate revenue growth
What are RDNT's Sales? Visit RDNT's Sales by Segment


  News about Radnet Inc Revenue per employee

RadNet Reduces Interest Rates and Celebrates Record Revenue While Pioneering AI Innovations in Diagnostic Imaging,

IntroductionIn a significant financial maneuver, RadNet, Inc. (NASDAQ: RDNT), a leader in outpatient diagnostic imaging services, has announced the reduction of its credit facility interest rates. This comes hand-in-hand with impressive revenue growth, highlighting RadNet s resilience and tactical positioning in the competitive healthcare landscape. Additionally, the company is set to leverage cutting-edge technology through a recent collaboration with GE HealthCare, further expanding its commitment to innovative healthcare solutions.Reduction in Interest RatesOn November 22, 2024, RadNet announced the successful pricing and allocation for Amendment No. 1 to its Credit and Guaranty Agreement. The First Amendment allows for a 0.25% reduction in interest rates under its Third Amended and Restated First Lien Credit and Guaranty Agreement. This strategic position is expected to enhance RadNet s financial flexibility, allowing for potential reinvestment in state-of-the-art imaging technologies and infrastructure.




Other Ratios
Radnet Inc 's Income per Employee
Employees in Medical Laboratories
Medical Laboratories Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
RDNT's Revenue per Employee versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for RDNT's Competitors
Revenue per Employee for RDNT's Suppliers
Revenue per Employee for RDNT's Customers

You may also want to know
RDNT's Sales Growth Rates RDNT's Pe Price to earnings ratio RDNT's Receivables Turnover Ratio RDNT's Stock Quote
RDNT's Net Income Growth Rates RDNT's Ps Price to Sales ratio RDNT's Sales per Employee RDNT's Asset Turnover Ratio
RDNT's Net Margin RDNT's Pb Price to Book ratio RDNT's Financial Strength Ratios RDNT's Dividend Payout Ratio
Date modified: 2026-08-12T20:45:56+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Angiodynamics Inc   502,731.01 $ 317.726  Million 632 
Zimmer Biomet Holdings Inc   500,517.65 $ 8,508.800  Million 17,000 
Biofrontera Inc   499,521.74 $ 45.956  Million 92 
Accuray Incorporated  495,467.24 $ 400.833  Million 809 
Resmed Inc   495,001.76 $ 5,628.170  Million 11,370 
Adaptive Biotechnologies Corporation  493,719.55 $ 308.081  Million 624 
Carlsmed Inc   491,787.40 $ 62.457  Million 127 
Viatris Inc   491,243.33 $ 14,737.300  Million 30,000 
Invivyd Inc   478,401.64 $ 58.365  Million 122 
Maravai Lifesciences Holdings Inc   477,898.85 $ 207.886  Million 435 
Moderna Inc   474,042.55 $ 2,228.000  Million 4,700 
Guardant Health Inc   472,108.94 $ 1,183.105  Million 2,506 
Neuropace Inc   471,866.03 $ 98.620  Million 209 
Skinhealth Systems Inc   471,817.29 $ 289.224  Million 613 
Pelthos Therapeutics Inc   470,695.65 $ 43.304  Million 92 
Inogen Inc   470,523.24 $ 354.304  Million 753 
Regenxbio Inc   470,301.89 $ 174.482  Million 371 
4d Molecular Therapeutics Inc   469,428.57 $ 92.008  Million 196 
Stryker Corp  461,375.00 $ 25,837.000  Million 56,000 
Atara Biotherapeutics Inc   460,857.14 $ 6.452  Million 14 
Glaukos Corp  457,066.73 $ 500.031  Million 1,094 
Treace Medical Concepts Inc   456,237.78 $ 205.307  Million 450 
Medpace Holdings Inc   448,756.13 $ 2,782.288  Million 6,200 
Sight Sciences Inc   448,123.66 $ 83.351  Million 186 
Dexcom Inc   447,639.64 $ 4,968.800  Million 11,100 
Haemonetics Corporation  447,145.88 $ 1,351.722  Million 3,023 
Nakamoto Inc   445,571.28 $ 28.962  Million 65 
Livanova Plc  445,488.48 $ 1,470.112  Million 3,300 
Rockwell Medical inc   444,757.96 $ 69.827  Million 157 
Teladoc Health Inc   444,550.00 $ 2,489.480  Million 5,600 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.